Methylcytosine Dioxygenase TET2 (TET2) Antibody

Methylcytosine Dioxygenase TET2 (TET2) Antibody
292.5€ (80 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Methylcytosine Dioxygenase TET2 (TET2) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx029485
Tested Applications
ELISA, WB, IHC

Description

TET2 may catalyze the conversion of methylcytosine (5mC) to 5-hydroxymethylcytosine (hmC) (By similarity). Play an important role in the regulation of myelopoiesis.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Methylcytosine Dioxygenase TET2 (TET2)
Immunogen: KLH-conjugated synthetic peptide between 528-554 amino acids from the N-terminal region of human TET2.
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1/2000, IHC-P: 1/100. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
Calculated MW: 224 kDa
Purification
Purified through a protein A column, followed by peptide affinity purification.
Size 1
80 µl
Size 2
400 µl
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS containing 0.09% sodium azide.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q6N021
Alias
IMD75,KIAA1546,MDS
Background
Antibody anti-TET2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

TET2 is a member of the TET family of dioxygenases that catalyzes the conversion of 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) in DNA, promoting active DNA demethylation and epigenetic regulation. TET2 is widely expressed in hematopoietic cells and plays a critical role in stem cell self-renewal, differentiation, and lineage commitment. It acts as a tumor suppressor by maintaining genomic stability and ensuring proper gene expression patterns, particularly in hematopoiesis. Loss-of-function mutations in TET2 are frequently observed in myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and other hematological malignancies, where they disrupt DNA methylation balance, alter gene regulation, and promote uncontrolled proliferation. TET2 also regulates immune responses by modulating T cell differentiation and inflammatory gene expression. Knockout studies in mice demonstrate enhanced hematopoietic stem cell self-renewal, impaired differentiation, and increased susceptibility to leukemogenesis, emphasizing TET2's role in DNA methylation dynamics, tumor suppression, and immune regulation.

Productos relacionados

abx001284

Methylcytosine Dioxygenase TET2 (TET2) Antibody

TET2 Antibody is a Rabbit Polyclonal antibody against TET2. TET2 (Tet oncogene family member 2), also known as KIAA1546,…

Ver producto
abx004345

Methylcytosine Dioxygenase TET2 (TET2) Antibody

TET2 Antibody is a Rabbit Polyclonal antibody against TET2. The protein encoded by this gene is a methylcytosine dioxyge…

Ver producto
abx029485

Methylcytosine Dioxygenase TET2 (TET2) Antibody

TET2 may catalyze the conversion of methylcytosine (5mC) to 5-hydroxymethylcytosine (hmC) (By similarity). Play an impor…

Ver producto